Fungi evolved over a billion years ago - long before plants - reshaping the timeline of early life and Earth’s first ...
Taysha Gene Therapies shares fall after regaining full rights to Rett syndrome drug TSHA-102 and finalizing FDA alignment for ...
The 2022 Option Agreement between Astellas and Taysha has expiredRegaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus ...
Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...
Nanoplastics, according to one study, can damage DNA, disrupt cell functions, and cause chronic inflammation. These materials ...
With the release of a study that links the use of nitrogen fertilizer in combination with antibiotic pesticides to escalating ...
Iowa State University researchers have unlocked new secrets within the bacteria responsible for the creation of thousands of ...
Gene tree and species tree reconciliation is a pivotal framework in evolutionary biology that bridges the evolutionary histories of individual gene families with the broader context of species ...
Researchers in Japan have genetically transferred a unique courtship behavior from one fruit fly species to another. By turning on a single gene in insulin-producing neurons, the team successfully ...
An important new study links pesticides, antibiotics, and nitrogen fertilizers to the extreme global crisis of antibiotic ...
In the latest quarter, 6 analysts provided ratings for Taysha Gene Therapies (NASDAQ:TSHA), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback